DrugPatentWatch Database Preview
Drugs in Development Information for Bitopertin
» See Plans and Pricing
What is the drug development status for Bitopertin?
Bitopertin is an investigational drug.
There have been 10 clinical trials for Bitopertin.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2010.
The most common disease conditions in clinical trials are Schizophrenia, beta-Thalassemia, and Psychotic Disorders. The leading clinical trial sponsors are Hoffmann-La Roche, Niuvanniemi Hospital, and Karolinska Institutet.
There are thirteen US patents protecting this investigational drug and one hundred and seventy-four international patents.
Summary for Bitopertin
| US Patents | 13 |
| International Patents | 174 |
| US Patent Applications | 23 |
| WIPO Patent Applications | 10 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2010-12-01) |
| Vendors | 52 |
Recent Clinical Trials for Bitopertin
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent Beta-Thalassemia | Hoffmann-La Roche | Phase 2 |
| A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers. | Hoffmann-La Roche | Phase 1 |
| Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial. | Karolinska Institutet | Phase 2 |
Clinical Trial Summary for Bitopertin
Top disease conditions for Bitopertin
Top clinical trial sponsors for Bitopertin
US Patents for Bitopertin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Bitopertin | Start Trial | 5-HT3 receptor antagonists | Takeda Pharmaceutical Company Limited (Osaka-Shi, Osaka, JP) | Start Trial |
| Bitopertin | Start Trial | Crystalline form of 1-(1-methyl-1H-pyrazol-4-yl)-N-((IR,5S,7S)-9-methyl-3-oxa-9-azabicyclo[3.- 3.1]nonan-7-yl)-1H-indole-3-carboxamide | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| Bitopertin | Start Trial | 5-HT3 receptor antagonists | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| Bitopertin | Start Trial | Benzoyl-piperazine derivatives | Hoffmann-La Roche Inc. (Nutley, NJ) | Start Trial |
| Bitopertin | Start Trial | Benzoyl-piperazine derivatives | Hoffmann-La Roche Inc. (Nutley, NJ) | Start Trial |
| Bitopertin | Start Trial | Synthesis of GlyT-1 inhibitors | Hoffman-La Roche Inc. (Nutley, NJ) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Bitopertin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Bitopertin | Argentina | 091781 | 2032-07-17 | Start Trial |
| Bitopertin | Australia | 2013290375 | 2032-07-17 | Start Trial |
| Bitopertin | Brazil | 112015001028 | 2032-07-17 | Start Trial |
| Bitopertin | Canada | 2879115 | 2032-07-17 | Start Trial |
| Bitopertin | Chile | 2015000121 | 2032-07-17 | Start Trial |
| Bitopertin | China | 104768943 | 2032-07-17 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
